Novartis plans Ayurveda debut

The Indian arm of Swiss pharmaceutical major Novartis AG is set to become the newest entrant in the Ayurvedic business. Novartis, already a major player in the Indian over-the-counter (OTC) segment......

Novartis to focus on alliances

The $25 billion Novartis AG has identified 'alliance model' as its growth strategy in India. The Swiss drug maker is exploring collaborations with Indian pharmaceutical companies in all possible......

US sues Novartis, alleging kickbacks to pharmacies

Novartis disputes the claims and will defend itself, spokeswoman Julie Masow said in an email.The US government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the......

Novartis may revise open offer price

Switzerland-based, Novartis AG, the parent company of Novartis India, is likely to revise its open offer price to buy back an additional stake of up to 39 per cent of equity to increase its......